Produces a synergistic IOP-lowering effect inside the eye, Timolol, Brinzolamide, Azarga, May cause transient blurred vision after instillation, Brinzolamide, Timolol, Azarga, May cause bronchoconstriction in asthmatic patients, Azarga, Timolol, Brinzolamide, Improves patient compliance by reducing the number of eye drops, Brinzolamide, Azarga , Timolol, Used when monotherapy fails to adequately control IOP, Azarga, Brinzolamide, Timolol, May interfere with acid–base balance at the cellular level, Azarga, Brinzolamide, Timolol, Timolol may cause systemic cardiovascular effects despite topical administration., True , False, Azarga combines a prostaglandin analogue with a carbonic anhydrase inhibitor., False, True, Brinzolamide inhibits carbonic anhydrase II within the ciliary body., False , True, Azarga improves patient adherence by reducing the number of daily eye drops., False, True.

Leaderboard

Visual style

Options

Switch template

)
Continue editing: ?